Vedolizumab is administered through a needle placed in a vein (intravenous infusion) in your arm. It is administered to you over a period of about 30 minutes. Your healthcare practitioner will monitor you while and after the entyvio infusion for the adverse reactions in order to see if you have a reaction to the treatment.
Most common adverse reactions include fever, common cold, joint pain, nausea, headache, infections of the nose and throat, tiredness, flu, cough, bronchitis, back pain, rash, itching, throat pain, sinus infection, and pain in the extremities.
Care should be exercised in the handling of Vedolizumab. Vedolizumab injections should not be opened or crushed. Unopened vials should be refrigerated at 2° to 8°C (36°-46°F). It should be retained in the original package in order to protect from light.
WHAT IS VEDOLIZUMAB AND WHAT IT IS USED FOR:
Vedolizumab specifically is an integrin receptor antagonist drug, indicated for the treatment of: